D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASRT
2051
DELISTED
Assertio
ASRT
| $2.09M | ﹤0.01% |
53,652
-21,458
| -29% | -$1.36M |
|
|
PRAH
2052
DELISTED
PRA Health Sciences, Inc.
PRAH
| $2.09M | ﹤0.01% |
+25,192
| New | +$2.46M |
|
2053
PUT
Avis
CAR
$5.78B
| $2.09M | ﹤0.01% |
150,400
| – | – |
|
2054
PUT
Verisk Analytics
VRSK
$28.1B
| $2.09M | ﹤0.01% |
15,000
+1,500
| +11% | +$235K |
|
2055
Kohl's
KSS
$2.16B
| $2.09M | ﹤0.01% |
143,252
-425,493
| -75% | -$15.9M |
|
|
OSG
2056
DELISTED
Overseas Shipholding Group Inc.
OSG
| $2.09M | ﹤0.01% |
919,865
-267,743
| -23% | -$540K |
|
2057
The Ensign Group
ENSG
$10.6B
| $2.09M | ﹤0.01% |
+55,503
| New | +$2.43M |
|
2058
Patterson-UTI
PTEN
$3.48B
| $2.08M | ﹤0.01% |
886,874
-134,543
| -13% | -$871K |
|
2059
CALL
uniQure
QURE
$2.46B
| $2.08M | ﹤0.01% |
43,900
| – | – |
|
2060
CALL
Viatris
VTRS
$20.7B
| $2.08M | ﹤0.01% |
139,700
-62,100
| -31% | -$1.19M |
|
2061
CALL
Wingstop
WING
$3.73B
| $2.08M | ﹤0.01% |
26,100
-10,000
| -28% | -$856K |
|
2062
Albemarle
ALB
$13.4B
| $2.08M | ﹤0.01% |
36,877
+30,002
| +436% | +$2.3M |
|
2063
Pricesmart
PSMT
$5.83B
| $2.07M | ﹤0.01% |
39,412
+32,677
| +485% | +$1.91M |
|
|
KEM
2064
DELISTED
KEMET Corporation
KEM
| $2.07M | ﹤0.01% |
+85,697
| New | +$2.17M |
|
2065
CALL
CarMax
KMX
$8.26B
| $2.07M | ﹤0.01% |
38,400
+700
| +2% | +$59.2K |
|
|
GWPH
2066
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.06M | ﹤0.01% |
23,500
-15,000
| -39% | -$1.59M |
|
2067
Bloomin' Brands
BLMN
$740M
| $2.06M | ﹤0.01% |
288,069
-262,074
| -48% | -$4.56M |
|
|
DSSI
2068
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
| $2.06M | ﹤0.01% |
+173,974
| New | +$2.04M |
|
2069
Cigna
CI
$79.7B
| $2.05M | ﹤0.01% |
11,596
+810
| +8% | +$157K |
|
|
FTCH
2070
PUT
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $2.05M | ﹤0.01% |
260,000
+190,000
| +271% | +$2.05M |
|
|
XENT
2071
DELISTED
Intersect ENT, Inc
XENT
| $2.04M | ﹤0.01% |
172,569
-287,563
| -62% | -$6.38M |
|
|
MDLA
2072
DELISTED
Medallia, Inc.
MDLA
| $2.04M | ﹤0.01% |
101,845
+78,043
| +328% | +$2.1M |
|
2073
PUT
MetLife
MET
$62.5B
| $2.03M | ﹤0.01% |
66,400
-121,300
| -65% | -$5.38M |
|
2074
Lesaka Technologies
LSAK
$393M
| $2.03M | ﹤0.01% |
696,870
-121,634
| -15% | -$450K |
|
2075
Worthington Enterprises
WOR
$2.84B
| $2.02M | ﹤0.01% |
125,059
+24,226
| +24% | +$506K |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.